Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer's disease

Jeroen VANBRABANT, Development Scientist, Doctor of Philosophy, ADx NeuroSciences, Gent, R&D

Clinical significance of fluid biomarkers in Alzheimer's Disease

Frontiers Linking Plasma Amyloid Beta and Neurofilament Light

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation - ScienceDirect

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults

BLOOD DERIVED AMYLOID BIOMARKERS FOR ALZHEIMER'S

Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias - ScienceDirect

Investigating Compensatory Brain Activity in Older Adults with Subjective Cognitive Decline - IOS Press

Amyloid-beta uptake by blood monocytes is reduced with ageing and

Blood-based biomarkers for Alzheimer's disease: towards clinical implementation - ScienceDirect

PDF) Plasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline

The informed road map to prevention of Alzheimer Disease: A call to arms, Molecular Neurodegeneration